[go: up one dir, main page]

MA52638A - Inhibiteurs d'abhd12 et leurs procédés de fabrication et d'utilisation - Google Patents

Inhibiteurs d'abhd12 et leurs procédés de fabrication et d'utilisation

Info

Publication number
MA52638A
MA52638A MA052638A MA52638A MA52638A MA 52638 A MA52638 A MA 52638A MA 052638 A MA052638 A MA 052638A MA 52638 A MA52638 A MA 52638A MA 52638 A MA52638 A MA 52638A
Authority
MA
Morocco
Prior art keywords
abhd12
inhibitors
manufacturing
use procedures
procedures
Prior art date
Application number
MA052638A
Other languages
English (en)
Inventor
Benjamin F Cravatt
Jonathan Hulce
Taka-Aki Ichu
Daisuke Ogasawara
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of MA52638A publication Critical patent/MA52638A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA052638A 2018-05-15 2019-05-14 Inhibiteurs d'abhd12 et leurs procédés de fabrication et d'utilisation MA52638A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862671998P 2018-05-15 2018-05-15

Publications (1)

Publication Number Publication Date
MA52638A true MA52638A (fr) 2021-03-24

Family

ID=68540848

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052638A MA52638A (fr) 2018-05-15 2019-05-14 Inhibiteurs d'abhd12 et leurs procédés de fabrication et d'utilisation

Country Status (7)

Country Link
US (1) US11897865B2 (fr)
EP (1) EP3793552B1 (fr)
JP (1) JP7282104B2 (fr)
CN (1) CN112105355B (fr)
ES (1) ES2952333T3 (fr)
MA (1) MA52638A (fr)
WO (1) WO2019222267A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3793552B1 (fr) 2018-05-15 2023-07-12 The Scripps Research Institute Inhibiteurs d'abhd12 et leurs procédés de fabrication et d'utilisation
ES2971502T3 (es) * 2019-05-14 2024-06-05 H Lundbeck As Inhibidores de ABHD12 y procedimientos de producción y uso de los mismos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946476B2 (en) * 2000-12-21 2005-09-20 Schering Corporation Heteroaryl urea neuropeptide Y Y5 receptor antagonists
CN1482912A (zh) 2000-12-21 2004-03-17 ���鹫˾ 杂芳基脲神经肽yy5受体拮抗剂
ES2639621T3 (es) * 2004-12-30 2017-10-27 Janssen Pharmaceutica N.V. Derivados de fenilamida del ácido 4-(bencil)-piperazina-1-carboxílico y compuestos relacionados como moduladores de la amida hidrolasa de ácidos grasos (FAAH) para el tratamiento de la ansiedad, el dolor y otras afecciones
CN101679258A (zh) 2007-03-13 2010-03-24 亚瑞特医疗公司 作为可溶性环氧化合物水解酶抑制剂的4-哌啶基脲化合物
EP2380991A1 (fr) 2010-04-20 2011-10-26 Universitätsklinikum Hamburg-Eppendorf Procédé pour déterminer le potentiel métastatique d'une tumeur
WO2016115463A1 (fr) * 2015-01-15 2016-07-21 Whitehead Institute For Biomedical Research Inhibiteurs de phosphoglycérate déshydrogénase (phgdh) et utilisations associées
US11273167B2 (en) * 2015-08-03 2022-03-15 The Regents Of The University Of California Compositions and methods for modulating ABHD2 activity
EP3793552B1 (fr) 2018-05-15 2023-07-12 The Scripps Research Institute Inhibiteurs d'abhd12 et leurs procédés de fabrication et d'utilisation
ES2971502T3 (es) 2019-05-14 2024-06-05 H Lundbeck As Inhibidores de ABHD12 y procedimientos de producción y uso de los mismos

Also Published As

Publication number Publication date
JP2021523902A (ja) 2021-09-09
EP3793552B1 (fr) 2023-07-12
CN112105355A (zh) 2020-12-18
CN112105355B (zh) 2024-01-02
EP3793552A4 (fr) 2022-02-16
WO2019222267A1 (fr) 2019-11-21
EP3793552C0 (fr) 2023-07-12
US11897865B2 (en) 2024-02-13
US20210221790A1 (en) 2021-07-22
ES2952333T3 (es) 2023-10-30
JP7282104B2 (ja) 2023-05-26
EP3793552A1 (fr) 2021-03-24

Similar Documents

Publication Publication Date Title
MA52488A (fr) Composés inhibiteurs de rip1 et leurs procédés de fabrication et d&#39;utilisation
MA51848A (fr) Inhibiteurs de kras g12c et leurs procédés d&#39;utilisation
MA52765A (fr) Inhibiteurs de kras g12c et leurs procédés d&#39;utilisation
MA52501A (fr) Inhibiteurs de kras g12c et leurs procédés d&#39;utilisation
MA52496A (fr) Inhibiteurs de kras g12c et leurs procédés d&#39;utilisation
MA50077A (fr) Inhibiteurs de kras g12c et leurs procédés d&#39;utilisation
MA48772A (fr) Inhibiteurs de kras g12c et leurs procédés d&#39;utilisation
EP3710430A4 (fr) Inhibiteurs d&#39;acss2 et leurs procédés d&#39;utilisation
EP3775203A4 (fr) Compositions d&#39;oligonucléotides et leurs procédés d&#39;utilisation
MA54538A (fr) Inhibiteurs d&#39;apol1 et leurs procédés d&#39;utilisation
EP3368538A4 (fr) Inhibiteurs de la kinase wee 1 et leurs procédés de fabrication et d&#39;utilisation
MA49950A (fr) Anticorps anti-b7-h4 et leurs procédés d&#39;utilisation
EP3720386A4 (fr) Constructions cutanées multicouches et leurs procédés de fabrication et d&#39;utilisation
EP3641774A4 (fr) Composition gélifiée à base de pectine et leurs procédés de fabrication et d&#39;utilisation
EP3684364A4 (fr) Pyridazinones et leurs procédés d&#39;utilisation
EP3630199A4 (fr) Compositions d&#39;oligonucléotides et leurs procédés d&#39;utilisation
EP3630789A4 (fr) Compositions d&#39;oligonucléotides et leurs procédés d&#39;utilisation
EP3436048A4 (fr) Néoantigènes et leurs procédés d&#39;utilisation
EP3867936A4 (fr) Éponges nano-graphitiques et leurs procédés de fabrication
EP3400097A4 (fr) Mélangeurs à bifurcation et leurs procédés d&#39;utilisation et de fabrication
EP3737579C0 (fr) Véhicules autonomes et leurs procédés d&#39;utilisation
EP3846808A4 (fr) Inhibiteurs de papd5 et leurs procédés d&#39;utilisation
EP3852533A4 (fr) Pyridazinones et leurs procédés d&#39;utilisation
EP3688373A4 (fr) Brûleurs et leurs procédés d&#39;utilisation
MA48793A (fr) Procédés de fabrication et d&#39;utilisation d&#39;inhibiteurs de pde9